Anemia Alert - NAAC's Monthly E-Newsletter for Medical Professionals

Volume 7, Issue 10

Newly Published Anemia Information from NAAC:
 

Featured Article: • Outlining Drug-Induced Anemia and Select Medications
Announcements:
 
 
• Important Label Changes for Dexferrum®, Iron Dextran Injections
• November is American Diabetes Month
• Ninth Cooley’s Anemia Symposium Held October 21-24 in NYC
Research Review:• Comparing ESA Dosing Regimens for Anemic CKD Patients
Ask the Experts:
 
 
 
 
• Administering Iron to Anemic Children with Bacterial Pneumonia
• Evaluating Causes of Chronic Anemia in Elderly Patients
• Optimizing ESA Doses to Achieve Maximal Hb Response
• Effectiveness and Tolerability of Iron Peptonate Preparations
• Considering Transfusion for Hemochromatosis Patients
For Your Patients:• Anemia and Nutritional Deficiencies Following Bariatric Surgery

Thank you for subscribing to Anemia Alert, NAAC's monthly e-newsletter for medical professionals. Every item described in this issue can be viewed in full on the NAAC website using the links provided.
Send to a Colleague  |  Sign-up for Anemia Alert  |  Unsubscribe  |  www.anemia.org

---------------------------------------------------------------------------------------------------------

Featured Article

Outlining Drug-Induced Anemia and Select Medications

Anemia can be a consequence of nutritional deficiencies or chronic diseases, but it may also occur from the treatment of the disease itself. Several types of drugs have been reported to cause different forms of anemia, including aplastic anemia, megaloblastic anemia, hemolytic anemia, and anemia caused by blood loss, chronic inflammation or suppression of red blood cell production. This article outlines a range of medications which can lead to these types of anemia so that you may be able to prevent or minimize drug-induced cases of anemia.

Read Full Article  |  Read Past Articles »

---------------------------------------------------------------------------------------------------------

NAAC Announcements

Important Label Changes for Dexferrum®, Iron Dextran Injections

Changes were recently made to the prescribing information for the drug Dexferrum®, an iron dextran injection used to treat iron deficiency anemia. The changes emphasize the warning about the risk of anaphylactic-type reactions and precautionary measures to mitigate the risk. Read Full News Item

American Diabetes Month

November is American Diabetes Month. Throughout the month, the American Diabetes Association aims to bring greater awareness and attention to the seriousness of diabetes, the importance of proper diabetes control, and its potentially life-threatening complications such as heart disease, stroke, kidney disease, blindness and amputation.
Read Full Event Item

Ninth Cooley’s Anemia Symposium Held October 21-24 in NYC

NEW YORK, NY – The Ninth Cooley’s Anemia Symposium, sponsored by the Cooley’s Anemia Foundation and the New York Academy of Sciences, is being held October 21-24, 2009 in New York City, NY. The symposium will integrate basic science and clinical research so that scientists and clinicians can develop a mutual understanding of recent Cooley's logoprogress in thalassemia. For more information, visit the foundation’s meeting website.

Read Past: News | Press Releases | Events

---------------------------------------------------------------------------------------------------------

Research Reviews

Comparing ESA Dosing Regimens for Anemic Kidney Disease Patients

Pergola et al conducted a randomized, open label, multicenter study to test the hypothesis that extended dosing regimens of epoetin alfa would be as safe and effective as approved dosing regimens, concluding that extended dosing regimens were not inferior to the standard three times per week dosing regimen when used to treat anemia in subjects with stage 3-4 CKD. Unfortunately, the increased dose required for significant extension of the dosing interval would make this approach untenable in the anticipated environment of bundled payments for dialysis services. Until our understanding of the basic physiology improves, we will be continuing to use ESAs in a largely empirical fashion rather than based on the important and distinctive pharmacokinetics and pharmacodynamics of individual agents.

Read Full Summary and Expert Commentary »

Pergola PE, Gartenberg G, Fu M, Wolfson M, Rao S, Bowers P. A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia. Clin J Am Soc Nephrol. 2009 Sep 17.

Read More Research Reviews »

---------------------------------------------------------------------------------------------------------

Ask the NAAC Experts

Administering Iron to Anemic Children with Bacterial Pneumonia

During treatment of children with bacterial pneumonia and concomitant iron deficiency anemia, is it appropriate to administer iron orally or intravenously?
Read NAAC’s Expert Response »

Evaluating Causes of Chronic Anemia in Elderly Patients

Do you have any recommendations for evaluation or treatment of an elderly woman (83 years of age) with chronic, severe anemia that requires a blood transfusion every 12-18 months to reinstate hemoglobin status?
Read NAAC’s Expert Response »

Optimizing ESA Dosing Regimens to Achieve Maximal Hb Response

Regarding the pharmacodynamics of erythropoiesis-stimulating agents (ESAs), how can clinicians achieve optimal erythropoietin serum levels in patients with adequate stored iron?
Read NAAC’s Expert Response »

Effectiveness and Tolerability of Iron Peptonate Preparations

What are the data on the absorption and efficacy of iron peptonate preparations that are marketed as neutriceuticals?
Read NAAC’s Expert Response »

Considering Red Blood Cell Transfusion for Hemochromatosis Patients

Is there any available evidence from published studies or guidelines to indicate whether or not anemic hemochromatosis patients should receive a red blood cell transfusion?
Read NAAC’s Expert Response »

 
Submit Your Questions OR Read More Q&A’s »

---------------------------------------------------------------------------------------------------------

For Your Patients

Anemia and Nutritional Deficiencies Following Bariatric Surgery

Bariatric surgery, also known as weight loss surgery, has become increasingly popular in recent years to help the morbidly obese permanently reduce their weight. In the past decade the number of surgeries has increased more than 10-fold with about 220,000 surgeries taking place in the United States in 2008 alone. Despite its increasing popularity and considerable success, bariatric surgery does not come without important nutritional considerations. Many bariatric patients develop new or worsen preexisting iron and vitamin deficiencies, with some patients becoming anemic in the months and years following the procedure. This article discusses how nutritional deficiencies can develop and provides tips on how to avoid deficiencies and anemia following the procedure.

Read Full Article  |  Read Past Articles For Patients »

---------------------------------------------------------------------------------------------------------

You have received Anemia Alert because you either subscribed to the newsletter or NAAC felt you may have an interest. Please follow the links below to manage your correspondence with NAAC.

Send to a Colleague  |  Sign-up for Anemia Alert  |  Unsubscribe  |  Remove Me

Copyright 2009 | National Anemia Action Council, Inc. | 555 E Wells St, Suite 1100, Milwaukee, WI 53202

Anemia Alert, the NAAC website and the content therein are for general informational and educational purposes and are not intended for use as the sole basis for medical judgments or decisions. Please review our full Terms of Use and Privacy Policy before using Anemia Alert or the NAAC website. The content of this newsletter was developed independently and without any input from sponsors.